Early Detection of Vaping-related Vascular Diseases

Launched by UNIVERSITY OF MIAMI · Jul 7, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how vaping affects blood vessels, especially in the lungs. Researchers want to find out if there is early damage to these blood vessels in people who use electronic cigarettes. The study is currently recruiting participants, and they are looking for two groups: one group of people aged 18-40 who currently use Puff Bars (a type of e-cigarette) for at least six months, and a second group of healthy adults in the same age range who have never smoked or vaped.

If you are interested in participating, you should know that the study excludes anyone who has used traditional cigarettes, other tobacco products, or marijuana, as well as those with certain health conditions like asthma or diabetes. Participants can expect to undergo tests to check the health of their blood vessels, helping researchers better understand the impacts of vaping. Overall, this trial aims to shed light on potential health risks associated with vaping that may not be immediately obvious.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Vapers Group:
• • 1. Current electronic cigarette (EC) Puff Bar users defined as using EC either daily or occasionally in the past 30 days for at least 6 months, and with 5% nicotine concentration pods.
• • 2. Adults aged 18-40 years
• Healthy Group:
• • 1. Healthy never smokers, never vapers
• • 2. Adults aged 18-40 years
• Exclusion Criteria:
• • 1. Current or past smoking of tobacco cigarette (TC) or other tobacco/nicotine products (e.g., smokeless tobacco, Hookah) or marijuana will be excluded from the study.
• • 2. Subjects with self-reported history of chronic health problems including asthma, chronic obstructive pulmonary disease (COPD), morbid obesity (BMI\>40 kg/m2), hypertension or diabetes
• • 3. Pregnant or breastfeeding women